24 September 2018 - BEAM AllianceAntibiorésistance : BEAM Alliance tire la sonnette d’alarmePriorités : Alerter les pouvoirs publics sur le besoin médical et l’urgence associés à la pénurie de nouveaux traitements contre…read more >>
07 June 2018 - BEAM AllianceBEAM writes to Representatives of the US congress to support The Pandemic and All Hazards Preparedeness Act (PAHPA) currently discussed at the House of Representatives.BEAM writes to Representatives of the US congress to support The Pandemic and All Hazards Preparedeness Act (PAHPA) currently discussed…read more >>
05 April 2018 - BEAM AllianceEU-JAMRAI: BEAM Alliance becomes a new stakeholderEU-JAMRAI [EU Joint Action on Antimicrobial Resistance (AMR) & Healthcare-Associated Infections (HCAI)] invited BEAM Alliance to take part as a new…read more >>
07 March 2018 - BEAM AllianceBEAM Alliance speaking at the 10th Community of Users Meeting – Health session “Preparedness and response to Infectious Disease Threats” in BrusselsFlorence Séjourné, President of the BEAM Alliance, presents the SME position in a round table on medical countermeasures towards policy…read more >>
15 February 2018 - BEAM AlliancePharmaceutiques, Janvier 2018 : Dossier Antibiothérapie – Incitations à l’investissementDes médicaments coûteux à développer, un marché restreint et peu prédictible : des schémas de soutien à la R&D et…read more >>
15 February 2018 - BEAM AlliancePharmaceutiques, Janvier 2018 : Dossier Antibiothérapie – Menace bactérienneFace à la montée en puissance des infections bactériennes résistantes aux antibiotiques, la communauté mondiale se met en marche. La…read more >>
20 March 2019 - Motif Bio plcMotif Bio Granted Meeting with U.S. FDA regarding Iclaprim“We are pleased that the FDA has granted our meeting request and that critical personnel from the FDA have been…read more >>
19 March 2019 - Pulmocide LtdFungal Update Meeting 2019: First Case Report of PC945 Treatment of Refectory Aspergillus Anastomotic Infection in a Lung Transplant RecipientFirst Case Report of PC945 Treatment of Refectory Aspergillus Anastomotic Infection in a Lung Transplant Recipientread more >>
18 February 2019 - NovaBiotics LtdNovaBiotics Awarded £1.8m in Small Business Research Innovation-Innovate UK grant funding to Advance its Antifungal Drug Candidate, NovamycinThe £1.8 million project aims to transform Novamycin from an exciting, laboratory-stage antifungal compound to a fully formulated antifungal drug…read more >>
14 February 2019 - Motif Bio plcMotif Bio Receives Complete Response Letter from the FDAGraham Lumsden, Chief Executive Officer of Motif Bio, said: “We are disappointed for patients and providers seeking an alternative antibiotic…read more >>
04 February 2019 - Polyphor LtdPolyphor awarded grant from CARB-X of up to $5.6M to support development of novel antibiotic against multi-drug resistant Gram-negative pathogensCARB-X provides Polyphor with initial funding of up to $2.6 million and up to $3.0 million more if certain project…read more >>
31 January 2019 - DEINOVEDeinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partnerDNV3837 is a first-in-class antibiotic candidate targeting the treatment of Clostridium difficile infections (CDIs), a disease classified as a priority…read more >>
05 June 2019Advancing Data Technologies to corner Antimicrobial ResistanceAntimicrobial resistance (AMR) already now is the largest global threat to Health and Food Safety (source: WHO). Without the focused…read more >>
03 June 2019BIO International ConventionThe key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO…read more >>
03 June 20196th World Congress and Exhibition on Antibiotics and Antibiotic ResistanceTheme: Challenges and New Concepts in Antibiotics Researchread more >>
22 May 2019NAPD Symposium ‘Accelerating antibiotic development in Europe’The Netherlands Antibiotic Development Platform (NADP) is organizing its second annual meeting, titled 'Accelerating antibiotic development in Europe'. The program…read more >>
13 April 201929th ECCMIDESCMID's yearly congress attracts nearly 13'000 participants. ECCMID offers a wide range of sessions including: keynotes, symposia, poster sessions, educational…read more >>
09 April 2019GARDP webinar: Mining Chemical Libraries for New AntibacterialsDespite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has…read more >>
28 March 2019GARDP webinar: Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional ProductsThe overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks…read more >>
26 March 2019Antimocrobial Resistance: Preventing an antibiotic apocalypseThe world is facing an imminent crisis of antimicrobial resistance (AMR). A growing range of disease-causing bacteria are proving difficult…read more >>
25 March 2019Bio-Europe Spring, 13th Annual International Partnering ConferenceBIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from…read more >>
